<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39368536</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0295</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Regulatory toxicology and pharmacology : RTP</Title><ISOAbbreviation>Regul Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Quantitative Risk Assessments of Skin Sensitisation for 26 Allergens in Different Consumer Products in the Saudi Market.</ArticleTitle><Pagination><StartPage>105714</StartPage><MedlinePgn>105714</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yrtph.2024.105714</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0273-2300(24)00155-7</ELocationID><Abstract><AbstractText>Fragrance chemicals are ubiquitous in cosmetics; however, they have been linked to allergic contact dermatitis. Allergy prevention involves two main strategies. Firstly, consumers are protected by limiting the maximum concentration of fragrance in a given product to avoid inducing allergies. Secondly, consumers who are already sensitized are protected by having the presence of such fragrance communicated to them. In this study, a validated GC-MS method was employed to quantify 26 allergens in 108 products marketed in Saudi Arabia.Additionally, a quantitative risk assessment (QRA) was performed on the studied cosmetics to determine the risk of inducing allergies. The results indicated that most allergens were present at acceptable concentrations, while 19 products carried a risk of inducing allergies. Furthermore, Lilial and Lyral, two prohibited fragrances, were detected in 97 products. It should be emphasized that this is the first study conducted in Saudi Arabia to evaluate the safety of the well-known 26 fragrance allergens. Hence, this study can potentially serve as a regional standard for future research.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Mussallam</LastName><ForeName>Adnan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshathri</LastName><ForeName>Rawan S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desmedt</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medicines and Health Products, Sciensano, Julliette Wytsmanstraat 14, 1050, Elsene, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldawsari</LastName><ForeName>Fahad S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deconinck</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medicines and Health Products, Sciensano, Julliette Wytsmanstraat 14, 1050, Elsene, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharthi</LastName><ForeName>Omniyah A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bawazir</LastName><ForeName>Abdullah T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Regul Toxicol Pharmacol</MedlineTA><NlmUniqueID>8214983</NlmUniqueID><ISSNLinking>0273-2300</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368536</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2024.105714</ArticleId><ArticleId IdType="pii">S0273-2300(24)00155-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>